| |
| |
|
| Insider
Information: |
Cardoza George |
| Relationship: |
President & COO, Lab Ops |
| City: |
Fort Myers |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
244,157 |
|
|
Indirect Shares
|
20,000 |
|
|
| Direct
Value |
$3,452,380 |
|
|
|
Indirect Value
|
$282,800 |
|
|
| Total
Shares |
264,157 |
|
|
| Total
Value |
$3,735,180 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -95.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NeoGenomics Inc |
NEO |
President & COO, Lab Ops |
2022-03-02 |
244,157 |
2022-03-02 |
20,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NEO |
NeoGenomics Inc |
President & COO, Lab Ops |
• – – |
2022-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(839) |
244,157 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President & COO, Lab Ops |
• – – |
2022-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(503) |
244,996 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President & COO, Lab Ops |
• – – |
2021-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
61,143 |
245,499 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President & COO, Lab Ops |
• – – |
2021-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,584 |
184,356 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2021-06-03 |
4 |
S |
$40.11 |
$1,247,702 |
D/D |
(31,107) |
176,772 |
0 |
% |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2021-06-02 |
4 |
S |
$40.39 |
$6,835,200 |
D/D |
(169,230) |
207,879 |
0 |
% |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2021-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,207 |
377,109 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2020-11-25 |
4 |
OE |
$7.52 |
$579,596 |
D/D |
77,074 |
447,976 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2020-11-25 |
4 |
S |
$45.48 |
$3,505,326 |
D/D |
(77,074) |
370,902 |
0 |
% |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2020-11-24 |
4 |
S |
$45.19 |
$2,391,726 |
D/D |
(52,926) |
370,902 |
0 |
% |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2020-11-24 |
4 |
OE |
$7.52 |
$548,404 |
D/D |
72,926 |
423,828 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2020-08-06 |
4 |
S |
$39.35 |
$3,246,375 |
D/D |
(82,500) |
350,902 |
0 |
% |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2020-08-06 |
4 |
OE |
$7.15 |
$715,000 |
D/D |
100,000 |
433,402 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,571 |
333,402 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2019-11-12 |
4 |
S |
$23.15 |
$450,129 |
D/D |
(19,444) |
325,831 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2019-11-12 |
4 |
OE |
$7.15 |
$317,775 |
D/D |
44,444 |
345,275 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2019-11-07 |
4 |
S |
$22.80 |
$91,200 |
D/D |
(4,000) |
300,831 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2019-11-06 |
4 |
S |
$22.82 |
$1,176,508 |
D/D |
(51,556) |
304,831 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2019-11-06 |
4 |
OE |
$7.15 |
$397,225 |
D/D |
55,556 |
356,387 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2019-05-03 |
4 |
S |
$22.82 |
$3,461,246 |
D/D |
(151,676) |
300,831 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2019-05-02 |
4 |
OE |
$4.78 |
$956,000 |
D/D |
200,000 |
452,507 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,418 |
252,507 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2019-02-27 |
4 |
OE |
$3.45 |
$103,500 |
D/D |
30,000 |
244,089 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
President, Pharma Services |
• – – |
2018-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,333 |
197,422 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Chief Financial Officer |
• – – |
2016-03-11 |
4 |
OE |
$1.46 |
$146,000 |
D/D |
100,000 |
221,089 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
